A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation

NCT00210613 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

199

Enrollment

INDUSTRY

Sponsor class

Conditions

Sexual Dysfunction
Ejaculation

Interventions

DRUG: Dapoxetine

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.